PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.
J Endocrinol Invest
; 46(10): 2185-2188, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-36933169
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Telomerase
Limits:
Humans
Language:
En
Journal:
J Endocrinol Invest
Year:
2023
Document type:
Article
Affiliation country:
Italy